CY1761A - Aerosol composition comprising nitroglycerin as active ingredient - Google Patents

Aerosol composition comprising nitroglycerin as active ingredient

Info

Publication number
CY1761A
CY1761A CY176194A CY176194A CY1761A CY 1761 A CY1761 A CY 1761A CY 176194 A CY176194 A CY 176194A CY 176194 A CY176194 A CY 176194A CY 1761 A CY1761 A CY 1761A
Authority
CY
Cyprus
Prior art keywords
nitroglycerin
active ingredient
aerosol composition
aerosol
composition
Prior art date
Application number
CY176194A
Other languages
English (en)
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of CY1761A publication Critical patent/CY1761A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K3/00—Materials not provided for elsewhere
    • C09K3/30—Materials not provided for elsewhere for aerosols

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Materials Engineering (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
CY176194A 1988-07-08 1994-07-15 Aerosol composition comprising nitroglycerin as active ingredient CY1761A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU883585A HU199678B (en) 1988-07-08 1988-07-08 Process for producing aerosols containing nitroglicerol

Publications (1)

Publication Number Publication Date
CY1761A true CY1761A (en) 1994-07-15

Family

ID=10964655

Family Applications (1)

Application Number Title Priority Date Filing Date
CY176194A CY1761A (en) 1988-07-08 1994-07-15 Aerosol composition comprising nitroglycerin as active ingredient

Country Status (15)

Country Link
US (1) US5047230A (xx)
JP (1) JPH0651620B2 (xx)
AT (1) AT401613B (xx)
BE (1) BE1003253A3 (xx)
BG (1) BG89108A (xx)
CH (1) CH679371A5 (xx)
CY (1) CY1761A (xx)
DE (1) DE3922650A1 (xx)
FR (1) FR2633933B1 (xx)
GB (1) GB2220949B (xx)
HU (1) HU199678B (xx)
IT (1) IT1230742B (xx)
NL (1) NL8901751A (xx)
RU (1) RU1837871C (xx)
UA (1) UA11237A (xx)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104984351A (zh) * 2015-06-15 2015-10-21 马应龙药业集团股份有限公司 一种硝酸甘油丙二醇溶液的制备方法

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4007705C1 (xx) * 1990-03-10 1991-09-26 G. Pohl-Boskamp Gmbh & Co. Chemisch-Pharmazeutische Fabrik, 2214 Hohenlockstedt, De
US5370862A (en) * 1990-06-13 1994-12-06 Schwarz Pharma Ag Pharmaceutical hydrophilic spray containing nitroglycerin for treating angina
DE4018919C2 (de) * 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray
DE4026072A1 (de) * 1990-08-17 1992-02-20 Sanol Arznei Schwarz Gmbh Nitroglycerinhaltiger, hydrophiler, waessriger pumpspray
DE4038203A1 (de) * 1990-11-30 1992-06-04 Kali Chemie Pharma Gmbh Pharmazeutische spray-zubereitungen mit coronaraktiven wirkstoffen
WO1995032715A1 (en) * 1994-05-27 1995-12-07 Neptune Pharmaceutical Corporation Nitric oxide donor composition and method for treatment of anal disorders
ES2183001T3 (es) * 1995-06-27 2003-03-16 Boehringer Ingelheim Pharma Nuevo preparado medicamentoso estable para la produccion de aerosoles exentos de gas propulsor.
AU2190697A (en) * 1996-04-12 1997-11-07 Flemington Pharmaceutical Corporation Buccal polar spray or capsule
US20030095927A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating muscular and skeletal disorders
US20040141923A1 (en) * 1997-10-01 2004-07-22 Dugger Harry A. Buccal, polar and non-polar spray containing alprazolam
US20050180923A1 (en) * 1997-10-01 2005-08-18 Dugger Harry A.Iii Buccal, polar and non-polar spray containing testosterone
US20090162300A1 (en) * 1997-10-01 2009-06-25 Dugger Iii Harry A Buccal, polar and non-polar spray containing alprazolam
US20040136913A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing sumatriptan
ES2293875T3 (es) 1997-10-01 2008-04-01 Novadel Pharma Inc. Aerosol bucal no polar.
US20030082107A1 (en) * 1997-10-01 2003-05-01 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating an infectious disease or cancer
US20040136914A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing ondansetron
US20050281752A1 (en) * 1997-10-01 2005-12-22 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030095925A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating metabolic disorders
US20030185761A1 (en) * 1997-10-01 2003-10-02 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US7632517B2 (en) * 1997-10-01 2009-12-15 Novadel Pharma Inc. Buccal, polar and non-polar spray containing zolpidem
US20050287075A1 (en) * 1997-10-01 2005-12-29 Dugger Harry A Iii Buccal, polar and non-polar spray or capsule containing drugs for treating pain
US20030077229A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing cardiovascular or renal drugs
US20030095926A1 (en) * 1997-10-01 2003-05-22 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract
US20030077227A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system
US20030190286A1 (en) * 1997-10-01 2003-10-09 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating allergies or asthma
US20050163719A1 (en) * 1997-10-01 2005-07-28 Dugger Harry A.Iii Buccal, polar and non-polar spray containing diazepam
US20050002867A1 (en) * 1997-10-01 2005-01-06 Novadel Pharma Inc. Buccal, polar and non-polar sprays containing propofol
US20040136915A1 (en) * 1997-10-01 2004-07-15 Dugger Harry A. Buccal, polar and non-polar spray containing atropine
US20030077228A1 (en) * 1997-10-01 2003-04-24 Dugger Harry A. Buccal, polar and non-polar spray or capsule containing drugs for treating endocrine disorders
DE19855097A1 (de) * 1998-11-28 2000-05-31 Wella Ag Pigmenthaltiges, verschäumbares Gel
WO2000047203A1 (en) * 1999-02-12 2000-08-17 Mqs, Inc. Formulation and system for intra-oral delivery of pharmaceutical agents
US10004684B2 (en) 2001-02-14 2018-06-26 Gw Pharma Limited Pharmaceutical formulations
GB0417675D0 (en) * 2004-08-09 2004-09-08 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
AU2006214166B2 (en) * 2005-02-17 2011-09-29 Zoetis Belgium S.A. Transmucosal administration of drug compositions for treating and preventing disorders in animals
GB0602224D0 (en) * 2006-02-03 2006-03-15 Futura Medical Dev Ltd Composition for promoting vascular smooth muscle relaxation
CA2649895C (en) * 2006-04-19 2013-03-26 Novadel Pharma Inc. Stable hydroalcoholic oral spray formulations and methods
US20080171089A1 (en) * 2006-12-22 2008-07-17 Blondino Frank E Stable anti-nausea oral spray formulations and methods
BRPI0811430A2 (pt) * 2007-05-10 2015-06-23 Novadel Pharma Inc Composições anti-insônia e processos
DE202008008079U1 (de) * 2008-06-16 2008-09-04 G. Pohl-Boskamp Gmbh & Co. Kg Pharmazeutische Zubereitung in Wasserdampf durchlässigen Behältern mit verbesserter Stabilität
CA2806636C (en) 2010-08-03 2018-01-23 G. Pohl-Boskamp Gmbh & Co. Kg Use of glyceryl trinitrate for treating traumatic edema
ES2672261T3 (es) 2011-02-25 2018-06-13 G. Pohl-Boskamp Gmbh & Co. Kg Gránulos estabilizados que contienen trinitrato de glicerilo
US9248099B2 (en) 2012-05-31 2016-02-02 Desmoid Aktiengesellschaft Use of stabilized granules containing glyceryl trinitrate for arteriogenesis
HUE033092T2 (hu) 2012-05-31 2017-11-28 G Pohl-Boskamp Gmbh & Co Kg Arteriogenezis indukálása nitroglicerinnel mint nitrogén-oxid donorral
EP2878310B1 (en) * 2013-11-29 2017-01-11 G. Pohl-Boskamp GmbH & Co. KG Sprayable aqueous composition comprising glyceryl trinitrate
CN113125596B (zh) * 2021-04-07 2023-01-13 马应龙药业集团股份有限公司 一种高效液相色谱法测定硝酸甘油软膏中有关物质的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE632504A (xx) * 1962-05-24
US4001391A (en) * 1969-04-18 1977-01-04 Plough, Inc. Means for depositing aerosol sprays in buttery form
US4369173A (en) * 1974-11-27 1983-01-18 Wickhen Products, Inc. Antiperspirant compositions
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
DE3109783C2 (de) * 1981-03-13 1987-04-02 Schwarz GmbH, 4019 Monheim Verfahren zur Herstellung einer ethanolfreien Nitroglycerinlösung mit einer Konzentration von etwa 1 mg Nitroglycerin/ml
US4440777A (en) * 1981-07-07 1984-04-03 Merck & Co., Inc. Use of eucalyptol for enhancing skin permeation of bio-affecting agents
DE3246081A1 (de) * 1982-12-13 1984-06-14 G. Pohl-Boskamp GmbH & Co Chemisch-pharmazeutische Fabrik, 2214 Hohenlockstedt Nitroglycerin-spray
EP0175671A1 (de) * 1984-08-23 1986-03-26 Kuhlemann & Co. Pharmazeutische Zubereitung sowie Verfahren zum Darreichen dieser pharmazeutischen Zubereitung
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
DE3613187A1 (de) * 1986-04-18 1987-10-22 Mack Chem Pharm Verwendung einer carbonsaeure in zur topischen anwendung bestimmten pharmazeutischen zubereitungen
JPH0645538B2 (ja) * 1987-09-30 1994-06-15 日本化薬株式会社 ニトログリセリンスプレー剤
DE4018919C2 (de) * 1990-06-13 1994-08-25 Sanol Arznei Schwarz Gmbh Nitroglycerin-Spray

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104984351A (zh) * 2015-06-15 2015-10-21 马应龙药业集团股份有限公司 一种硝酸甘油丙二醇溶液的制备方法

Also Published As

Publication number Publication date
JPH0651620B2 (ja) 1994-07-06
FR2633933B1 (fr) 1994-07-22
GB8915632D0 (en) 1989-08-23
IT8921118A0 (it) 1989-07-07
AT401613B (de) 1996-10-25
UA11237A (uk) 1996-12-25
BE1003253A3 (fr) 1992-02-11
US5047230A (en) 1991-09-10
IT1230742B (it) 1991-10-29
HU199678B (en) 1990-03-28
FR2633933A1 (fr) 1990-01-12
ATA165489A (de) 1996-03-15
GB2220949B (en) 1992-01-22
JPH02142726A (ja) 1990-05-31
NL8901751A (nl) 1990-02-01
CH679371A5 (xx) 1992-02-14
DE3922650C2 (xx) 1993-03-04
RU1837871C (ru) 1993-08-30
BG89108A (bg) 1993-12-24
GB2220949A (en) 1990-01-24
DE3922650A1 (de) 1990-01-11

Similar Documents

Publication Publication Date Title
GB2220949B (en) Aerosol composition comprising nitroglycerin as active ingredient
HU900221D0 (en) Fungicid composition comprising acyl-amino-benzamides as active ingredient and process for preparation thereof
EP0372777A3 (en) Medicinal aerosol formulations
EP0423695A3 (en) Aerosol composition for topical medicament
HUT49625A (en) Process for producing macrolid compounds and pharmaceutical compositions comprising such active ingredient
HUT52083A (en) Herbicidal compositions comprising cyclohexenone oxymetres as active ingredient and process for producing the active ingredients
ZA896982B (en) Pharmaceutical compositions which have a relaxing activity and which contain a nitrate ester as active substance
HUT43233A (en) Synergic insecticidal compositions comprising active substance combination
EG18772A (en) Arthropodicidal compositions containing several pyrethriodal active ingredient
EG20222A (en) An oxazoline compound its production and insecticides and/or acoricides containing the same as an active ingredient
HUT49370A (en) Process for producing polypeptides and pharmaceutical compositions comprising same as active ingredient
HUT46660A (en) Process for producing 3-alkoxy-2-amino-propyl-amines and pharmaceutical compositions comprising the same as active ingredient
HU900865D0 (en) Fungicidal compositions comprising 2-anilino-cyanopyridines and process for preparation of the active ingredient
HU900209D0 (en) Herbicid composition comprising n-phenyl-tetrahidroindazol-derivatives as active ingredient and process for preparation thereof
GB2224654B (en) Insecticidal composition for an aerosol
HU900075D0 (en) Herbicid composition comprising sulfonyl-urea as active ingredient and process for preparation thereof
HUT49575A (en) Insecticidal compositions comprising imidate derivatives as active ingredient
HU896610D0 (en) Herbicid composition comprising substituted-sulfonyl-urea as active ingredient and process for preparation thereof
DE3163391D1 (en) A pharmaceutical composition containing a benzofuran-carboxamide derivative as the active ingredient
RO105644B1 (ro) Compozitie insecticida
AU625769B2 (en) 2-ethoxymethyl-5-hydroxy-gamma-pyrone and melanogenesis- inhibiting endermic preparation containing the same compound as active ingredient
HU903014D0 (en) Herbicide compositions containing 2-phenyl-perhydro-isoindol-1-one or -1-thione derivatives as active ingredient and process for the preparation of 2-phenyl-perhydro-isoindol-1-one and -1-thione derivatives
HUT41228A (en) Microbicide compositions containing new 2,4-dichloro-5-nitro-thiazole as active ingredient and process for preparing the active substance
GB2161706B (en) New pharmaceutical and cosmetic compositions containing 10-acetyl-1,8,9-triacetoxyanthracene as active ingredient
GB8905489D0 (en) Pharmaceutical composition comprising 3-(n-piperidino-azino)methylrifamycins as active ingredient